Submit 28 days trial results of Hepatitis C drug for Covid-19: CDSCO panel to Zydus Cadila Medical Dialogues Team21 April 2021 11:12 AM ISTNew Delhi: In response to the drug major Zydus Cadila's proposal for marketing authorisation of the Hepatitis C drug, Pegylated Interferon Alpha-2b...
COVID-19: Zydus Cadila seeks DCGI nod for Pegylated Interferon alpha-2b Medical Dialogues Bureau5 April 2021 11:24 AM ISTAhmedabad: Drugmaker, Zydus Cadila, announced that its Phase III clinical trials with Pegylated Interferon Alpha 2b, PegiHep has shown promising...
COVID-19: Zydus Cadila gets DCGI nod to start phase 3 trials with Pegylated Interferon alpha-2b in India Ruchika Sharma5 Dec 2020 12:17 PM ISTPegylated Interferon alpha-2b,'PegiHep' is an approved drug and is being re-purposed for the treatment of COVID-19.
Zydus Cadila Covid therapy PegiHep completes Phase II trial Ruchika Sharma13 Nov 2020 10:00 AM ISTAhmedabad: Zydus Cadila, has recently announced that the company has successfully completed a Phase 2 clinical trial in COVID-19 patients with...
Zydus Cadila seeks DCGI approval for clinical trial of hepatitis drug PegiHep in COVID-19 Ruchika Sharma6 May 2020 11:51 AM ISTPegylated Interferon Alpha-2b has been used in the treatment of COVID-19 in China and Cuba and is a part of the treatment guidelines of the Chinese...
